YC S25
Panoptive
Real-time defensible oversight for clinical trials
About
We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct. The platform aggregates findings and identifies systemic patterns across sites and subjects before they compound, and tracks every finding through decision, follow-up, and resolution.
Founder
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Panoptive.
See family office activityIndustry & Focus
B2BArtificial IntelligenceBiotechInfrastructure